Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-363-2 | CAS number: 7069-42-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- 09.08.1983 - 19.09.1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: scientifically acceptable
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The study was performed as a 14-day repeated dose oral toxicity study in mice with daily administration of the substance via gavage. Body weights
were measured but no histopathology and haematology was performed. - GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Retinyl propionate
- EC Number:
- 230-363-2
- EC Name:
- Retinyl propionate
- Cas Number:
- 7069-42-3
- Molecular formula:
- C23H34O2
- IUPAC Name:
- retinyl propionate
- Details on test material:
- - Lot/batch No.: 024004
- Stability under test conditions: refrigerator 10°C, protect from light, protect from air
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- not specified
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- peanut oil
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 14 days
- Frequency of treatment:
- once daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 24.25, 48.5, 97.0, 194.0, 388.0 (mg/kg)
Basis:
actual ingested
- No. of animals per sex per dose:
- 6 doses: each 5 females; 5 males
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- treatment of controls: peanut oil 5 ml/kg p.o.
Duration of study: 42 days
Results and discussion
Results of examinations
- Details on results:
- Signs of reaction after dosing: Weight loss, Ataxia, Body sag, Piloerection, Respiratory depression, Cachexia, Hair loss;
Mortalities: Groupe 5: all animals dead after 13th dosing;
Groupe 6: all animals dead after 7th dosing
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Table 1: Mortalities 28 days after 14th dosing | |||||
Groupe number: |
Dose level (mg/kg) |
Male | Female | Total | % |
1 | 0 | 0/5 | 0/5 | 0/10 | 0 |
2 | 24.25 | 0/5 | 0/5 | 0/10 | 0 |
3 | 48.5 | 0/5 | 0/5 | 0/10 | 0 |
4 | 97 | 1/5 | 0/5 | 1/10 | 10 |
5 | 194 | 5/5 | 5/5 | 10/10 | 100 |
6 | 388 | 5/5 | 5/5 | 10/10 | 100 |
Table 2: Body weight in g +/- SEM (groups means, n = No of animals weighed) | |||||
Groupe number: |
Dose level (mg/kg) |
Day of 1st dosing |
Day 1 | Day 14 of observation |
Day 28 |
1 | 0 | 21.0 +/- 0.3 (10) |
31.5 +/- 1.1 (10) |
37.1 +/- 1.2 (10) |
40.9 +/- 1.0 (10) |
2 | 24.25 | 20.9 +/- 0.3 (10) |
32.1 +/- 1.6 (10) |
38.8 +/- 1.6 (10) |
42.7 +/- 1.8 (10) |
3 | 48.5 | 20.6 +/- 0.4 (10) |
30.6 +/- 1.3 (10) |
38.7 +/- 1.6 (10) |
41.8 +/- 1.9 (10) |
4 | 97 | 20.3 +/- 0.3 (10) |
24.6 +/- 1.9 (10) |
33.6 +/- 2.0 (9) |
38.7 +/- 2.1 (9) |
5 | 194 | 21.0 +/- 0.3 (10) |
_--- | _--- | _--- |
6 | 388 | 20.7 +/- 0.4 (10) |
_--- | _--- | _--- |
Applicant's summary and conclusion
- Conclusions:
- The LD 50 after repeated oral administrations (once daily on 14 consecutive days) of Vitamin A propionate in mice of both sexes observed over a
period of 28 days was estimated to be 125 (90-175) mg/kg. There were observed signs of hypervitaminosis A.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
